{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:49:45Z","timestamp":1784893785813,"version":"3.55.0"},"reference-count":52,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Investigator Initiated Research grant from Eli Lilly","award":["I1F-NS-O004"],"award-info":[{"award-number":["I1F-NS-O004"]}]},{"name":"Investigator Initiated Research grant from Eli Lilly","award":["R188-A6597"],"award-info":[{"award-number":["R188-A6597"]}]},{"name":"Investigator Initiated Research grant from Eli Lilly","award":["OCAY-18-774-OFIL"],"award-info":[{"award-number":["OCAY-18-774-OFIL"]}]},{"name":"Danish Rheumatism Association","award":["I1F-NS-O004"],"award-info":[{"award-number":["I1F-NS-O004"]}]},{"name":"Danish Rheumatism Association","award":["R188-A6597"],"award-info":[{"award-number":["R188-A6597"]}]},{"name":"Danish Rheumatism Association","award":["OCAY-18-774-OFIL"],"award-info":[{"award-number":["OCAY-18-774-OFIL"]}]},{"name":"Elisabeth and Karl Ejnar Nis-Hanssens Mindelegat","award":["I1F-NS-O004"],"award-info":[{"award-number":["I1F-NS-O004"]}]},{"name":"Elisabeth and Karl Ejnar Nis-Hanssens Mindelegat","award":["R188-A6597"],"award-info":[{"award-number":["R188-A6597"]}]},{"name":"Elisabeth and Karl Ejnar Nis-Hanssens Mindelegat","award":["OCAY-18-774-OFIL"],"award-info":[{"award-number":["OCAY-18-774-OFIL"]}]},{"name":"Minister Erna Hamiltons Legat for Videnskab og Kunst","award":["I1F-NS-O004"],"award-info":[{"award-number":["I1F-NS-O004"]}]},{"name":"Minister Erna Hamiltons Legat for Videnskab og Kunst","award":["R188-A6597"],"award-info":[{"award-number":["R188-A6597"]}]},{"name":"Minister Erna Hamiltons Legat for Videnskab og Kunst","award":["OCAY-18-774-OFIL"],"award-info":[{"award-number":["OCAY-18-774-OFIL"]}]},{"name":"Overl\u00e6ge Johan Boserup og Lise Boserups Legat","award":["I1F-NS-O004"],"award-info":[{"award-number":["I1F-NS-O004"]}]},{"name":"Overl\u00e6ge Johan Boserup og Lise Boserups Legat","award":["R188-A6597"],"award-info":[{"award-number":["R188-A6597"]}]},{"name":"Overl\u00e6ge Johan Boserup og Lise Boserups Legat","award":["OCAY-18-774-OFIL"],"award-info":[{"award-number":["OCAY-18-774-OFIL"]}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["I1F-NS-O004"],"award-info":[{"award-number":["I1F-NS-O004"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["R188-A6597"],"award-info":[{"award-number":["R188-A6597"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OCAY-18-774-OFIL"],"award-info":[{"award-number":["OCAY-18-774-OFIL"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>This study aimed to explore the dynamic interactions between 32 cytokines and biomarkers in Psoriatic Arthritis (PsA) patients to compare cytokine signatures of treatment responders and non-responders. Biomarkers were measured before and after four months of treatment in 39 PsA patients initiating either Tumor Necrosis Factor alpha inhibitor (TNFi) or Interleukin-17A inhibitor (IL-17Ai). Response to treatment was defined by the composite measure, Disease Activity in Psoriatic Arthritis (DAPSA). A two-component principal component analysis (PCA) was implemented to describe cytokine signatures comparing DAPSA50 responders and non-responders. The cytokine signature of TNFi responders was driven by the correlated cytokines interferon \u03b3 (IFN\u03b3) and IL-6, additionally associated with IL-12\/IL-23p40, TNF\u03b1, and CRP, while the cytokine signature of TNFi non-responders was driven by the correlated cytokines IL-15, IL-8, and IFN\u03b3. IL-17Ai responders were characterized by contributions of strongly correlated Th17 inflammatory cytokines, IL-17A, IL-12\/IL-23p40, IL-22 to the cytokine signature, whereas IL-17A and IL-12\/IL-23p40 did not demonstrate significant contribution in IL-17Ai non-responders. Based on PCA results it was possible to differentiate DAPSA50 responders and non-responders to treatment, endorsing additional examination of cytokine interaction models in PsA patients and supporting further PsA patient immune stratification to improve individualized treatment of PsA patients.<\/jats:p>","DOI":"10.3390\/ijms24076343","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:37:15Z","timestamp":1679978235000},"page":"6343","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNF\u03b1 Inhibitors"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-4749","authenticated-orcid":false,"given":"Marie","family":"Skougaard","sequence":"first","affiliation":[{"name":"The Parker Institute, Bispebjerg and Frederiksberg Hospital, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark"},{"name":"Copenhagen Center for Translational Research, Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark"},{"name":"Department of Clinical Immunology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-9711","authenticated-orcid":false,"given":"Sisse Bolm","family":"Ditlev","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Translational Research, Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus Friis","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Translational Research, Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Erik","family":"Kristensen","sequence":"additional","affiliation":[{"name":"The Parker Institute, Bispebjerg and Frederiksberg Hospital, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","article-title":"Enthesitis: An autoinflammatory lesion linking nail and joint involvement in psoriatic disease","volume":"23","author":"McGonagle","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imm.12142","article-title":"Interleukin-17A: A unique pathway in immune-mediated diseases: Psoriasis, psoriatic arthritis and rheumatoid arthritis","volume":"141","author":"Kirkham","year":"2014","journal-title":"Immunology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2249.2007.03377.x","article-title":"Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10\/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA)","volume":"148","author":"Aggarwal","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13256","article-title":"Dendritic cells, T cells and their interaction in rheumatoid arthritis","volume":"196","author":"Wehr","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2007.08.009","article-title":"Immune regulation in psoriasis and psoriatic arthritis-Recent developments","volume":"114","author":"Hueber","year":"2007","journal-title":"Immunol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.672515","article-title":"From Bed to Bench and Back: TNF-\u03b1, IL-23\/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis","volume":"12","author":"Silvagni","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11926-019-0866-1","article-title":"Psoriatic Arthritis: Newer and Older Therapies","volume":"21","author":"Chao","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","article-title":"Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: A medical revolution","volume":"83","author":"Kuek","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"ref_14","first-page":"30","article-title":"Biologics-based therapy for the treatment of rheumatoid arthritis","volume":"91","author":"Scott","year":"2012","journal-title":"Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2018.08.025","article-title":"Differential efficacy of biologic treatments targeting the TNF-\u03b1\/IL-23\/IL-17 axis in psoriasis and psoriatic arthritis","volume":"111","author":"Furue","year":"2018","journal-title":"Cytokine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3899\/jrheum.150744","article-title":"Effectiveness and feasibility associated with switching to a second or third TNF inhibitor in patients with psoriatic arthritis: A cohort study from southern Sweden","volume":"43","author":"Kristensen","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases","volume":"20","author":"Ko","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","article-title":"IL-27-induced modulation of autoimmunity and its therapeutic potential","volume":"14","author":"Meka","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13075-016-1196-6","article-title":"Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis","volume":"18","author":"Muntyanu","year":"2016","journal-title":"Arthritis Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"713618","DOI":"10.1155\/2012\/713618","article-title":"Pathological Role of Interleukin-6 in Psoriatic Arthritis","volume":"2012","author":"Ogata","year":"2012","journal-title":"Arthritis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The immunobiology of interleukin-27","volume":"33","author":"Yoshida","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ard.62.2.113","article-title":"Interleukin 7 stimulates tumour necrosis factor \u03b1 and Th 1 cytokine production in joints of patients with rheumatoid arthritis","volume":"62","author":"Glaudemans","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","article-title":"IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFN\u03b3-producing T cells","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fphar.2017.00293","article-title":"A brief history of IL-1 and IL-1 Ra in rheumatology","volume":"8","author":"Dayer","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000357780","article-title":"The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis","volume":"21","author":"Vazirinejad","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajhg.2014.03.016","article-title":"Maximizing the power of principal-component analysis of correlated phenotypes in genome-wide association studies","volume":"94","author":"Aschard","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"570614","DOI":"10.3389\/fmed.2020.570614","article-title":"Identification of COVID-19 Clinical Phenotypes by Principal Component Analysis-Based Cluster Analysis","volume":"7","author":"Ye","year":"2020","journal-title":"Front. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e000656","DOI":"10.1136\/rmdopen-2018-000656","article-title":"Distinguishing rheumatoid arthritis from psoriatic arthritis","volume":"4","author":"Merola","year":"2018","journal-title":"RMD Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15476910903453296","article-title":"An overview of IL-7 biology and its use in immunotherapy","volume":"7","author":"Elkassar","year":"2010","journal-title":"J. Immunotoxicol."},{"key":"ref_31","first-page":"7453236","article-title":"IL-7 is a key driver cytokine in spondyloarthritis?","volume":"2019","author":"Duarte","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cytogfr.2012.10.001","article-title":"The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction","volume":"24","author":"Iannis","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.0801986","article-title":"TGF-\u03b2 Promotes Th17 Cell Development through Inhibition of SOCS3","volume":"183","author":"Qin","year":"2009","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_37","first-page":"5","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"71","year":"2015","journal-title":"Cytokine"},{"key":"ref_38","first-page":"4","article-title":"Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4236\/abb.2013.47A3002","article-title":"The talented interferon-gamma","volume":"4","author":"Lin","year":"2013","journal-title":"Adv. Biosci. Biotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2013.12.001","article-title":"IFN\u03b3 inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms","volume":"267","author":"Yeh","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13075-022-02956-x","article-title":"Four emerging immune cellular blood phenotypes associated with disease duration and activity established in Psoriatic Arthritis","volume":"24","author":"Skougaard","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.13280","article-title":"Cytokine-regulated Th17 plasticity in human health and diseases","volume":"163","author":"Cerboni","year":"2021","journal-title":"Immunology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/cei.12782","article-title":"The impact of disease activity and tumour necrosis factor-\u03b1 inhibitor therapy on cytokine levels in juvenile idiopathic arthritis","volume":"184","author":"Walters","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"675108","DOI":"10.1155\/2014\/675108","article-title":"Ankylosing spondylitis and rheumatoid arthritis: Serum levels of TNF- \u03b1 and its soluble receptors during the course of therapy with etanercept and infliximab","volume":"2014","author":"Schulz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.62.6.561","article-title":"Up regulation of the production of tumour necrosis factor \u03b1 and interferon \u03b3 by T cells in ankylosing spondylitis during treatment with etanercept","volume":"62","author":"Zou","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","article-title":"Disease activity in psoriatic arthritis (PsA): Defining remission and treatment success using the DAPSA score","volume":"75","author":"Schoels","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e010650","DOI":"10.1136\/bmjopen-2015-010650","article-title":"Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: Protocol for a prospective, exploratory cohort study","volume":"6","author":"Christensen","year":"2016","journal-title":"BMJ Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12967-020-02328-6","article-title":"Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial","volume":"18","author":"Nistor","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/757584395","article-title":"Rotation of principal components: Choice of normalization constraints","volume":"22","author":"Jolliffe","year":"1995","journal-title":"J. Appl. Stat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kez325","article-title":"The many faces of psoriatic arthritis: Their genetic determinism","volume":"59","author":"Winchester","year":"2020","journal-title":"Rheumatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:04:44Z","timestamp":1760123084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24076343"],"URL":"https:\/\/doi.org\/10.3390\/ijms24076343","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}